无肌松药喉罩通气全麻在腹腔镜下精索静脉高位结扎术中的应用

来源 :中国中西医结合麻醉学会年会暨第二届全国中西医结合麻醉学术研讨会 | 被引量 : 0次 | 上传用户:jianlzho
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:观察无肌松药SLIPA喉罩通气全麻用于腹腔镜下行精索静脉高位结扎术的可行性.方法:择期全麻下行腹腔镜精索静脉高位结扎术患者60例,ASA Ⅰ~Ⅱ级,年龄18~36岁,BMI<35kg/m2,排除合并严重系统疾病者,张口困难和特殊咽喉疾病者.随机分为无肌松药组(WN组)和肌松药组(N组),每组30例.N组麻醉诱导依次静注眯达唑仑0.05mg/kg、舒芬太尼1ug/kg、丙泊酚1~1.5mg/kg和罗库溴铵0.8mg/kg,待BIS≤50后,由同一位有经验的麻醉医师置入SLIPA喉罩(根据病人甲状软骨角间距选择49~53型号),确定位置后固定,行机械通气.
其他文献
Background: Programmed cell death 4 (PDCD4) is a newly defined transcriptional and translational inhibitor, and tumor suppressor.
Human gingival tissue-derived mesenchymal stem cells (GMSCs) are a convenient source of MSCs that have been shown to treat autoimmunc disease.
Background: We previously demonstrated that atorvastatin induced immature dendritic cells (DCs) derived from spleen in vitro.
Background aims.Mesenchymal stem cells (MSCs) and regulatory T cells (Treg) have been successfully used in treating autoimmune diseases accompanied by abundant inflammatory cytokines such as IFN-γ and
Aim: Blockade of the protein-protein interaction between the transmembrane programmed cell death 1 protein (PD-1) and its ligand PD-L1 emerges as a promising immunotherapy for treating cancer.
目的:建立小鼠原位气管移植模型,研究Th17细胞对移植物的影响。方法:供受体按体质量配对后随机分为6组,同系移植组:C57BL/6→C57BL/6 (n=10);同种移植组:BALB/c→C57BL/6 (n=10);IL-17AAb组:BALB/c→C57BL/6,注射anti-IL-17A抗体(n=10);IL-6 Ab组:BALB/c→C57BL/6,注射anti-IL-6抗体(n=10);
Objective: The purpose of this study was to ascertain if cytotoxic T lymphocyte antigen-4 (CTLA-4) playing an important role in the occurrence and progress of acute graft-versus-host disease (GVHD).
Background: Mycophenolate mofetil (MMF), which inhibits T and B lymphocyte proliferation, is widely used to treat a variety of autoimmune diseases, such as systemic lupus erythematosus (SLE) and lupus
研究背景:组蛋白修饰在免疫应答及重大疾病进展中功能的研究已逐渐成为免疫学研究的热点。前期,我们对14种已知参与H3K4甲基化修饰的酶进行siRNA介导的干扰普筛实验,发现Ashll在天然免疫应答和炎症发生发展中具有重大的调控作用。然而Ashll在适应性免疫应答中的调控作用仍亟待发现。
目的:观察经皮穴位电刺激(Transcutaneous Electrical Acupoint Stimulation,TEAS)对胃癌根治术患者 术后全身炎性反应综合征(SIRS)发生率及术后肺部并发症和肛门排气时间的影响。方法:择期全麻下行胃癌根治术患者204例,年龄40~75岁,随机分为经皮穴位电刺激组(TEAS group)、假经皮穴位电刺激组(Sham group)和对照组(contro